Therefore, we set out to evaluate the distribution and morphology of TDP-43 and dynactin pathology in patients with Perry disease, HMN7B, ALS, FTLD-MND, and hippocampal sclerosis (HpScl) in order to clarify Perry disease pathology [7]. Here, TARDBP is linked to mild neurocognitive disorder.